The mild encephalitis concept for psychiatric disorders revisited in the light of current psychoneuroimmunological findings

Neurology Psychiatry and Brain Research

Volumn 19, Issue 3, 2013, Pages 87-101

  Müller, Norbert ^a   Bechter, Karl ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Inflammation; Major depression; Mild encephalitis; Psychoneuroimmunology; Schizophrenia

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CELECOXIB; ETANERCEPT; FLUOXETINE; GLUTAMIC ACID; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; INDOLEAMINE 2,3 DIOXYGENASE; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; KYNURENIC ACID; KYNURENINE; MINOCYCLINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEOPTERIN; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN; PLACEBO; PROSTAGLANDIN SYNTHASE; QUINOLINIC ACID; SEROTONIN; SERTRALINE; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ANTIBODY BLOOD LEVEL; ASTROCYTE; AUTOIMMUNE DISEASE; BLOOD BRAIN BARRIER; BRAIN SIZE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CYTOKINE PRODUCTION; DEPRESSION; DISEASE EXACERBATION; ENCEPHALITIS; ENZYME INHIBITION; EPIDEMIOLOGICAL DATA; GENOTYPE ENVIRONMENT INTERACTION; HEREDITY; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOGLOBULIN PRODUCTION; IMMUNOREACTIVITY; MAJOR DEPRESSION; META ANALYSIS (TOPIC); MICROGLIA; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROIMAGING; NEUROTRANSMISSION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; RISK FACTOR; SCHIZOPHRENIA; TREATMENT RESPONSE;

EID: 84880569876     PISSN: 09419500     EISSN: 22128581     Source Type: Journal    
DOI: 10.1016/j.npbr.2013.04.004     Document Type: Review

References (230)

1. L.A. O'Neill How frustration leads to inflammation Science 320 2008 619 620
2. R. Hohlfeld, M. Kerschensteiner, and E. Meinl Dual role of inflammation in CNS disease Neurology 68 2007 S58 S63
3. D.R. Hanson, and I.I. Gottesman Theories of schizophrenia: a genetic-inflammatory-vascular synthesis BMC Medical Genetics 6 2005 7
4. A. Kutzelnigg, C.F. Lucchinetti, C. Stadelmann, W. Bruck, H. Rauschka, and M. Bergmann Cortical demyelination and diffuse white matter injury in multiple sclerosis Brain 128 2005 2705 2712 (Pubitemid 41552953)
5. E. Meinl, M. Krumbholz, T. Derfuss, A. Junker, and R. Hohlfeld Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis Journal of the Neurological Sciences 274 2008 42 44
6. M. Kerschensteiner, E. Meinl, and R. Hohlfeld Neuro-immune crosstalk in CNS diseases Neuroscience 158 2009 1122 1132
7. G. Anderson, M. Berk, S. Dodd, K. Bechter, A.C. Altamura, and B. Dell'osso Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia Progress in Neuro-Psychopharmacology and Biological Psychiatry 42 2013 1 4
8. K. Felgenhauer Psychiatric disorders in the encephalitic form of multiple sclerosis Journal of Neurology 237 1990 11 18 (Pubitemid 20072848)
9. L. Chiveri, M. Sciacco, and A. Prelle Schizophreniform disorder with cerebrospinal fluid PCR positivity for herpes simplex virus type 1 European Neurology 50 2003 182 183 (Pubitemid 37256056)
10. K.J. Oommen, P.C. Johnson, and C.G. Ray Herpes simplex type 2 virus encephalitis presenting as psychosis American Journal of Medicine 73 1982 445 448 (Pubitemid 12031800)
11. C. Fazekas, C. Enzinger, M. Wallner, U. Kischka, E. Greimel, and P. Kapeller Depressive symptoms following herpes simplex encephalitis - an underestimated phenomenon? General Hospital Psychiatry 28 2006 403 407 (Pubitemid 44572112)
12. H. Hiroshi, K. Seiji, K. Toshihiro, and K. Nobuo An adult case suspected of recurrent measles encephalitis with psychiatric symptoms Seishin Shinkeigaku Zasshi Psychiatria et Neurologia Japonica 105 2003 1239 1246
13. M.T. Mercadante, G.F. Busatto, P.J. Lombroso, L. Prado, M.C. Rosario-Campos, and V.R. do The psychiatric symptoms of rheumatic fever American Journal of Psychiatry 157 2000 2036 2038
14. A.L. Teixeira Jr., D.P. Maia, and F. Cardoso Psychosis following acute Sydenham's chorea European Child and Adolescent Psychiatry 16 2007 67 69 (Pubitemid 46648359)
15. J. Kerbeshian, L. Burd, and A. Tait Chain reaction or time bomb: a neuropsychiatric-developmental/neurodevelopmental formulation of tourettisms, pervasive developmental disorder, and schizophreniform symptomatology associated with PANDAS World Journal of Biological Psychiatry 8 2007 201 207 (Pubitemid 47163386)
16. K. Bechter, A. Bindl, M. Horn, and V. Schreiner Therapy-resistant depression with fatigue. A case of presumed streptococcal-associated autoimmune disorder Nervenarzt 78 338 2007 338 340 341
17. N. Müller, B. Gizycki-Nienhaus, W. Günther, and M. Meurer Depression as a cerebral manifestation of scleroderma: immunological findings in serum and cerebrospinal fluid Biological Psychiatry 31 1992 1151 1156
18. N. Müller, B. Gizycki-Nienhaus, C. Botschev, and M. Meurer Cerebral involvement of scleroderma presenting as schizophrenia-like psychosis Schizophrenia Research 10 1993 179 181 (Pubitemid 23273372)
19. A.P. van Dam Diagnosis and pathogenesis of CNS lupus Rheumatology International 11 1991 1 11
20. J. Nikolich-Zugich Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections Nature Reviews Immunology 8 2008 512 522 (Pubitemid 351913675)
21. K. Bechter Mild encephalitis underlying psychiatric disorders - a reconsideration and hypothesis exemplified on Borna disease Neurology, Psychiatry & Brain Research 9 2001 55 70 (Pubitemid 34309278)
22. D. Keizman, O. Rogowski, S. Berliner, M. Ish-Shalom, N. Maimon, and B. Nefussy Low-grade systemic inflammation in patients with amyotrophic lateral sclerosis Acta Neurologica Scandinavica 119 2009 383 389
23. R. Dantzer Cytokine-induced sickness behavior: where do we stand? Brain, Behavior, and Immunity 15 2001 7 24 (Pubitemid 33070866)
24. V.H. Perry Stress primes microglia to the presence of systemic inflammation: implications for environmental influences on the brain Brain, Behavior, and Immunity 21 2007 45 46 (Pubitemid 44854448)
25. C. Cunningham, D.C. Wilcockson, S. Campion, K. Lunnon, and V.H. Perry Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration Journal of Neuroscience 25 2005 9275 9284 (Pubitemid 41500836)
26. J.P. Godbout, and R.W. Johnson Age and neuroinflammation: a lifetime of psychoneuroimmune consequences Immunology and Allergy Clinics of North America 29 2009 321 337
27. N.L. Sparkman, and R.W. Johnson Neuroinflammation associated with aging sensitizes the brain to the effects of infection or stress Neuroimmunomodulation 15 2008 323 330
28. M.G. Frank, M.V. Baratta, D.B. Sprunger, L.R. Watkins, and S.F. Maier Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses Brain, Behavior, and Immunity 21 2007 47 59 (Pubitemid 44854445)
29. R. Brambilla, V. Bracchi-Ricard, W.H. Hu, B. Frydel, A. Bramwell, and S. Karmally Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury Journal of Experimental Medicine 202 2005 145 156 (Pubitemid 41002917)
30. C. Farina, F. Aloisi, and E. Meinl Astrocytes are active players in cerebral innate immunity Trends in Immunology 28 2007 138 145 (Pubitemid 46283692)
31. H.M. Gao, and J.S. Hong Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression Trends in Immunology 29 2008 357 365
32. E. Aronica, J.A. Gorter, H. Ijlst-Keizers, A.J. Rozemuller, B. Yankaya, and S. Leenstra Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins European Journal of Neuroscience 17 2003 2106 2118 (Pubitemid 36713971)
33. B. Wildemann, P. Oschmann, and H. Reiber Laboratory diagnosis in neurology 2010 Thieme Stuttgart
34. M. Schwartz, and R. Shechter Protective autoimmunity functions by intracranial immunosurveillance to support the mind: the missing link between health and disease Molecular Psychiatry 15 2010 342 354
35. N. Müller, and M. Ackenheil Immunoglobulin and albumin content of cerebrospinal fluid in schizophrenic patients: relationship to negative symptomatology Schizophrenia Research 14 1995 223 228
36. H. Hampel, S.F. Muller, C. Berger, A. Haberl, M. Ackenheil, and C. Hock Evidence of blood-cerebrospinal fluid-barrier impairment in a subgroup of patients with dementia of the Alzheimer type and major depression: a possible indicator for immunoactivation Dementia 6 1995 348 354
37. H. Hampel, H.U. Kotter, and H.J. Moller Blood-cerebrospinal fluid barrier dysfunction for high molecular weight proteins in Alzheimer disease and major depression: indication for disease subsets Alzheimer Disease and Associated Disorders 11 1997 78 87 (Pubitemid 27271977)
38. H. Hampel, H.U. Kotter, F. Padberg, D.A. Korschenhausen, and H.J. Moller Oligoclonal bands and blood-cerebrospinal-fluid barrier dysfunction in a subset of patients with Alzheimer disease: comparison with vascular dementia, major depression, and multiple sclerosis Alzheimer Disease and Associated Disorders 13 1999 9 19 (Pubitemid 29176517)
39. K. Bechter, H. Reiber, S. Herzog, D. Fuchs, H. Tumani, and H.G. Maxeiner Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood-CSF barrier dysfunction Journal of Psychiatric Research 44 2010 321 330
40. H.G. Maxeiner, M.T. Rojewski, A. Schmitt, H. Tumani, K. Bechter, and M. Schmitt Flow cytometric analysis of T cell subsets in paired samples of cerebrospinal fluid and peripheral blood from patients with neurological and psychiatric disorders Brain, Behavior, and Immunity 23 2009 134 142
41. L.K. Kuehne, H. Reiber, K. Bechter, L. Hagberg, and D. Fuchs Cerebrospinal fluid neopterin is brain-derived and not associated with blood CSF barrier dysfunction Acta Neurologica Scandinavica 2013 (in press)
42. H. Furukawa, R.A. del, G. Monge-Arditi, and H.O. Besedovsky Interleukin-1, but not stress, stimulates glucocorticoid output during early postnatal life in mice Annals of the New York Academy of Sciences 840 117-122 1998 117 122 (Pubitemid 28302042)
43. D. Zhou, A.W. Kusnecov, M.R. Shurin, M. DePaoli, and B.S. Rabin Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis Endocrinology 133 1993 2523 2530 (Pubitemid 24000698)
44. H. Anisman, Z. Merali, and S. Hayley Sensitization associated with stressors and cytokine treatments Brain, Behavior, and Immunity 17 2003 86 93 (Pubitemid 36369417)
45. S. Hayley, P. Wall, and H. Anisman Sensitization to the neuroendocrine, central monoamine and behavioural effects of murine tumor necrosis factor-alpha: peripheral and central mechanisms European Journal of Neuroscience 15 2002 1061 1076 (Pubitemid 35463640)
46. A. Nair, and R.H. Bonneau Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation Journal of Neuroimmunology 171 2006 72 85 (Pubitemid 41832279)
47. J.C. O'Connor, M.A. Lawson, C. Andre, E.M. Briley, S.S. Szegedi, and J. Lestage Induction of IDO by bacille Calmette-Guerin is responsible for development of murine depressive-like behavior Journal of Immunology 182 2009 3202 3212
48. C.L. Raison, and A.H. Miller The evolutionary significance of depression in pathogen host defense (PATHOS-D) Molecular Psychiatry 18 2013 15 37
49. A.D. Proal, and P.J. Albert The human microbiome and autoimmunity Current Opinion in Rheumatology 25 2 2013 234 240
50. T.R. Insel Rethinking schizophrenia Nature 468 2010 187 193
51. B.D. Pearce Viruses and psychiatric disorders A. Siegel, S.S. Zalcman, The neuroimmunological basis of behavior and mental disorders 2009 Springer New York 383 410
52. J. van Os, G. Kenis, and B.P. Rutten The environment and schizophrenia Nature 468 2010 203 212
53. R. Uher The role of genetic variation in the causation of mental illness: an evolution-informed framework Molecular Psychiatry 14 2009 1072 1082
54. A. Caspi, A.R. Hariri, A. Holmes, R. Uher, and T.E. Moffitt Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits American Journal of Psychiatry 167 2010 509 527
55. C. Dalman, P. Allebeck, D. Gunnell, G. Harrison, K. Kristensson, and G. Lewis Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects American Journal of Psychiatry 165 2008 59 65 (Pubitemid 351704553)
56. W.W. Eaton, M. Byrne, H. Ewald, O. Mors, C.Y. Chen, and E. Agerbo Association of schizophrenia and autoimmune diseases: linkage of Danish national registers American Journal of Psychiatry 163 2006 521 528 (Pubitemid 44469397)
57. K. Bechter, and A. Hodgkiss Research strategies in 'slow' infections in psychiatry History of Psychiatry 6 1995 503 511
58. D.H. Lee, and O. Vielemeyer Analysis of overall level of evidence behind Infectious Diseases Society of America practice guidelines Archives of Internal Medicine 171 2011 18 22
59. C.A. Glaser, S. Honarmand, L.J. Anderson, D.P. Schnurr, B. Forghani, and C.K. Cossen Beyond viruses: clinical profiles and etiologies associated with encephalitis Clinical Infectious Diseases 43 2006 1565 1577 (Pubitemid 44901899)
60. H. Pan, B.S. Yan, M. Rojas, Y.V. Shebzukhov, H. Zhou, and L. Kobzik Ipr1 gene mediates innate immunity to tuberculosis Nature 434 2005 767 772 (Pubitemid 44739520)
61. S. Herzog, K. Frese, and R. Rott Studies on the genetic control of resistance of black hooded rats to Borna disease Journal of General Virology 72 1991 535 540
62. O.B.K. Planz, and M. Schwemmle Human Borna disease virus infection K.M. Carbone, Borna disease virus - role in neurobehavioral disease 2002 ASM Press Washington 179 225
63. M.V. Ovanesov, K. Moldovan, K. Smith, M.W. Vogel, and M.V. Pletnikov Persistent Borna Disease Virus (BDV) infection activates microglia prior to a detectable loss of granule cells in the hippocampus Journal of Neuroinflammation 5 16 2008 16
64. J. Zubin, and B. Spring Vulnerability - a new view of schizophrenia Journal of Abnormal Psychology 86 1977 103 126
65. G.W. Brown, A. Bifulco, T. Harris, and L. Bridge Life stress, chronic subclinical symptoms and vulnerability to clinical depression Journal of Affective Disorders 11 1986 1 19 (Pubitemid 16045970)
66. U. Meyer, J. Feldon, and S.H. Fatemi In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders Neuroscience and Biobehavioral Reviews 33 2009 1061 1079
67. T.W. Pace, T.C. Mletzko, O. Alagbe, D.L. Musselman, C.B. Nemeroff, and A.H. Miller Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress American Journal of Psychiatry 163 2006 1630 1633 (Pubitemid 44465765)
68. A. Danese, T.E. Moffitt, C.M. Pariante, A. Ambler, R. Poulton, and A. Caspi Elevated inflammation levels in depressed adults with a history of childhood maltreatment Archives of General Psychiatry 65 2008 409 415
69. S. Claes, A.M. Myint, K. Domschke, J. Del-Favero, K. Entrich, and S. Engelborghs The kynurenine pathway in major depression: haplotype analysis of three related functional candidate genes Psychiatry Research 188 2011 355 360
70. D.A. Körschenhausen, H.J. Hampel, M. Ackenheil, R. Penning, and N. Müller Fibrin degradation products in post mortem brain tissue of schizophrenics: a possible marker for underlying inflammatory processes Schizophrenia Research 19 1996 103 109 (Pubitemid 26180478)
71. D.B. Wildenauer, D. Körschenhausen, W. Hoechtlen, M. Ackenheil, M. Kehl, and F. Lottspeich Analysis of cerebrospinal fluid from patients with psychiatric and neurological disorders by two-dimensional electrophoresis: identification of disease-associated polypeptides as fibrin fragments Electrophoresis 12 1991 487 492
72. N. Müller, and M.J. Schwarz Neuroimmune-endocrine crosstalk in schizophrenia and mood disorders Expert Review of Neurotherapeutics 6 2006 1017 1038 (Pubitemid 44060296)
73. N. Müller, and M.J. Schwarz Immune system and schizophrenia Current Immunology Reviews 6 2010 213 220
74. S. Potvin, E. Stip, A.A. Sepehry, A. Gendron, R. Bah, and E. Kouassi Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review Biological Psychiatry 63 2008 801 808 (Pubitemid 351410515)
75. A. Carlsson The current status of the dopamine hypothesis of schizophrenia Neuropsychopharmacology 1 1988 179 186 (Pubitemid 19126130)
76. Z.D. Ling, E.D. Potter, J.W. Lipton, and P.M. Carvey Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines Experimental Neurology 149 1998 411 423 (Pubitemid 28115079)
77. A. Kabiersch, H. Furukawa, R.A. del, and H.O. Besedovsky Administration of interleukin-1 at birth affects dopaminergic neurons in adult mice Annals of the New York Academy of Sciences 840 1998 123 127 (Pubitemid 28302043)
78. E.D. Potter, Z.D. Ling, and P.M. Carvey Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons Cell and Tissue Research 296 1999 235 246 (Pubitemid 29219176)
79. L.F. Jarskog, H. Xiao, M.B. Wilkie, J.M. Lauder, and J.H. Gilmore Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro International Journal of Developmental Neuroscience 15 1997 711 716 (Pubitemid 27478191)
80. C. Winter, A. Djodari-Irani, R. Sohr, R. Morgenstern, J. Feldon, and G. Juckel Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia International Journal of Neuropsychopharmacology 12 2009 513 524
81. B.T. Rouse, and S. Sehrawat Immunity and immunopathology to viruses: what decides the outcome? Nature Reviews Immunology 10 2010 514 526
82. N. Müller, and M.J. Schwarz The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view Journal of Neurotransmission Suppl. 72 2007 269 280
83. T.W. Stone Neuropharmacology of quinolinic and kynurenic acids Pharmacological Reviews 45 1993 309 379 (Pubitemid 23292874)
84. N. Müller, A.M. Myint, and M.J. Schwarz Kynurenine pathway in schizophrenia: pathophysiological and therapeutic aspects Current Pharmaceutical Design 17 2011 130 136
85. J. Steiner, M. Walter, W. Glanz, Z. Sarnyai, H.G. Bernstein, and S. Vielhaber Increased prevalence of diverse N-methyl-d-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-d-aspartate glutamate receptor encephalitis JAMA Psychiatry 70 2013 271 278
86. A. Vincent, and C.G. Bien Anti-NMDA-receptor encephalitis: a cause of psychiatric, seizure, and movement disorders in young adults The Lancet Neurology 7 2008 1074 1075
87. S. Erhardt, K. Blennow, C. Nordin, E. Skogh, L.H. Lindstrom, and G. Engberg Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia Neuroscience Letters 313 2001 96 98 (Pubitemid 32973903)
88. K.R. Linderholm, E. Skogh, S.K. Olsson, M.L. Dahl, M. Holtze, and G. Engberg Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia Schizophrenia Bulletin 38 2012 426 432
89. R. Schwarcz, A. Rassoulpour, H.Q. Wu, D. Medoff, C.A. Tamminga, and R.C. Roberts Increased cortical kynurenate content in schizophrenia Biological Psychiatry 50 2001 521 530 (Pubitemid 32971883)
90. K.V. Sathyasaikumar, E.K. Stachowski, I. Wonodi, R.C. Roberts, A. Rassoulpour, and R.P. McMahon Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia Schizophrenia Bulletin 37 2011 1147 1156
91. S.K. Olsson, A.S. Andersson, K.R. Linderholm, M. Holtze, L.K. Nilsson-Todd, and L. Schwieler Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia International Journal of Neuropsychopharmacology 12 2009 501 512
92. R. Condray, G.G. Dougherty, M.S. Keshavan, R.D. Reddy, G.L. Haas, and D.M. Montrose 3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia International Journal of Neuropsychopharmacology 14 2011 756 767
93. A.M. Myint, M.J. Schwarz, R. Verkerk, H.H. Mueller, J. Zach, and S. Scharpe Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naive and medication-free schizophrenic patients Brain, Behavior, and Immunity 25 2011 1576 1581
94. G. Ceresoli-Borroni, A. Rassoulpour, H.Q. Wu, P. Guidetti, and R. Schwarcz Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain Journal of Neural Transmission 113 10 2006 1355 1365 (Pubitemid 44435873)
95. U. Meyer, and J. Feldon Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia Psychopharmacology (Berl) 206 2009 587 602
96. U. Meyer, J. Feldon, and B.K. Yee A review of the fetal brain cytokine imbalance hypothesis of schizophrenia Schizophrenia Bulletin 35 2009 959 972
97. S.L. Buka, M.T. Tsuang, E.F. Torrey, M.A. Klebanoff, D. Bernstein, and R.H. Yolken Maternal infections and subsequent psychosis among offspring Archives of General Psychiatry 58 2001 1032 1037 (Pubitemid 33051828)
98. T. Westergaard, P.B. Mortensen, C.B. Pedersen, J. Wohlfahrt, and M. Melbye Exposure to prenatal and childhood infections and the risk of schizophrenia: suggestions from a study of sibship characteristics and influenza prevalence Archives of General Psychiatry 56 1999 993 998 (Pubitemid 29526382)
99. B.D. Pearce Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms Molecular Psychiatry 6 2001 634 646 (Pubitemid 33020582)
100. S.L. Buka, T.D. Cannon, E.F. Torrey, and R.H. Yolken Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring Biological Psychiatry 63 2008 809 815 (Pubitemid 351400765)
101. A.S. Brown, M.D. Begg, S. Gravenstein, C.A. Schaefer, R.J. Wyatt, and M. Bresnahan Serologic evidence of prenatal influenza in the etiology of schizophrenia Archives of General Psychiatry 61 2004 774 780 (Pubitemid 39031117)
102. A.S. Brown, P. Cohen, E.S. Susser, and M.A. Greenwald Nonaffective psychosis after prenatal exposure to rubella American Journal of Psychiatry 157 2000 438 443 (Pubitemid 30145931)
103. H.J. Sorensen, E.L. Mortensen, J.M. Reinisch, and S.A. Mednick Association between prenatal exposure to bacterial infection and risk of schizophrenia Schizophrenia Bulletin 35 2009 631 637
104. V. Babulas, P. Factor-Litvak, R. Goetz, C.A. Schaefer, and A.S. Brown Prenatal exposure to maternal genital and reproductive infections and adult schizophrenia American Journal of Psychiatry 163 2006 927 929 (Pubitemid 44464544)
105. A.S. Brown, C.A. Schaefer, C.P. Quesenberry Jr., L. Liu, V.P. Babulas, and E.S. Susser Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring American Journal of Psychiatry 162 2005 767 773 (Pubitemid 40489141)
106. P. Boksa Maternal infection during pregnancy and schizophrenia Journal of Psychiatry and Neuroscience 33 2008 183 185 (Pubitemid 351692417)
107. W.F. Gattaz, A.L. Abrahao, and R. Foccacia Childhood meningitis, brain maturation and the risk of psychosis European Archives of Psychiatry and Clinical Neuroscience 254 2004 23 26 (Pubitemid 39310545)
108. A.S. Brown The risk for schizophrenia from childhood and adult infections American Journal of Psychiatry 165 2008 7 10 (Pubitemid 351704543)
109. R.H. Yolken, and E.F. Torrey Viruses, schizophrenia, and bipolar disorder Clinical Microbiology Reviews 8 1995 131 145
110. F.M. Leweke, C.W. Gerth, D. Koethe, J. Klosterkotter, I. Ruslanova, and B. Krivogorsky Antibodies to infectious agents in individuals with recent onset schizophrenia European Archives of Psychiatry and Clinical Neuroscience 254 2004 4 8 (Pubitemid 39310542)
111. D. Krause, J. Matz, E. Weidinger, J. Wagner, A. Wildenauer, and M. Obermeier The association of infectious agents and schizophrenia The World Journal of Biological Psychiatry 11 2010 739 743
112. K. Bechter, S. Herzog, W. Behr, and R. Schuttler Investigations of cerebrospinal fluid in Borna disease virus seropositive psychiatric patients European Psychiatry 10 1995 250 258
113. U. Meyer, M.J. Schwarz, and N. Müller Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond Pharmacology & Therapeutics 132 2011 96 110
114. L.M. Ellman, R.F. Deicken, S. Vinogradov, W.S. Kremen, J.H. Poole, and D.M. Kern Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8 Schizophrenia Research 121 2010 46 54
115. M.E. Benros, P.R. Nielsen, M. Nordentoft, W.W. Eaton, S.O. Dalton, and P.B. Mortensen Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study American Journal of Psychiatry 168 2011 1303 1310
116. M.E. Benros, P.B. Mortensen, and W.W. Eaton Autoimmune diseases and infections as risk factors for schizophrenia Annals of the New York Academy of Sciences 1262 2012 56 66
117. R. Dantzer, J.C. O'Connor, G.G. Freund, R.W. Johnson, and K.W. Kelley From inflammation to sickness and depression: when the immune system subjugates the brain Nature Reviews Neuroscience 9 2008 46 56 (Pubitemid 350295688)
118. A. Reichenberg, R. Yirmiya, A. Schuld, T. Kraus, M. Haack, and A. Morag Cytokine-associated emotional and cognitive disturbances in humans Archives of General Psychiatry 58 2001 445 452 (Pubitemid 32411324)
119. A. Reichenberg, T. Kraus, M. Haack, A. Schuld, T. Pollmacher, and R. Yirmiya Endotoxin-induced changes in food consumption in healthy volunteers are associated with TNF-alpha and IL-6 secretion Psychoneuroendocrinology 27 2002 945 956 (Pubitemid 35279765)
120. S. Lanquillon, J.C. Krieg, U. Bening-Abu-Shach, and H. Vedder Cytokine production and treatment response in major depressive disorder Neuropsychopharmacology 22 2000 370 379 (Pubitemid 30105765)
121. S. Häfner, T.C. Baghai, D. Eser, C. Schüle, R. Rupprecht, and B. Bondy C-reactive protein is associated with polymorphisms of the angiotensin-converting enzyme gene in major depressed patients Journal of Psychiatric Research 42 2008 163 165 (Pubitemid 350061258)
122. M. Danner, S.V. Kasl, J.L. Abramson, and V. Vaccarino Association between depression and elevated C-reactive protein Psychosomatic Medicine 65 2003 347 356 (Pubitemid 36628886)
123. D.E. Ford, and T.P. Erlinger Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey Archives of Internal Medicine 164 2004 1010 1014 (Pubitemid 38581522)
124. M.A. Kling, S. Alesci, G. Csako, R. Costello, D.A. Luckenbaugh, and O. Bonne Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A Biological Psychiatry 62 2007 309 313 (Pubitemid 47449633)
125. G. Cizza, F. Eskandari, M. Coyle, P. Krishnamurthy, E.C. Wright, and S. Mistry Plasma CRP levels in premenopausal women with major depression: A 12-month controlled study Hormone and Metabolic Research 41 2009 641 648
126. D. Gimeno, M.G. Marmot, and A. Singh-Manoux Inflammatory markers and cognitive function in middle-aged adults: the Whitehall II study Psychoneuroendocrinology 33 2008 1322 1334
127. N. Müller, E. Hofschuster, M. Ackenheil, W. Mempel, and R. Eckstein Investigations of the cellular immunity during depression and the free interval: evidence for an immune activation in affective psychosis Progress in Neuro-Psychopharmacology and Biological Psychiatry 17 1993 713 730 (Pubitemid 23280948)
128. M. Maes, H.Y. Meltzer, E. Bosmans, R. Bergmans, E. Vandoolaeghe, and R. Ranjan Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression Journal of Affective Disorders 34 1995 301 309
129. M. Maes, H.Y. Meltzer, P. Buckley, and E. Bosmans Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression European Archives of Psychiatry and Clinical Neuroscience 244 1995 325 329
130. M. Irwin Immune correlates of depression Advances in Experimental Medicine and Biology 461 1999 1 24
131. S.O.V. Nunes, E.M.V. Reiche, H.K. Morimoto, T. Matsuo, E.N. Itano, and E.C.D. Xavier Immune and hormonal activity in adults suffering from depression Brazilian Journal of Medical and Biological Research 35 2002 581 587 (Pubitemid 34568226)
132. N. Müller, and M.J. Schwarz Immunology in anxiety and depression S. Kasper, J.A. den Boer, J.M.A. Sitsen, Handbook of depression and anxiety 2002 Marcel Dekker New York 267 288
133. O. Mikova, R. Yakimova, E. Bosmans, G. Kenis, and M. Maes Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis European Neuropsychopharmacology 11 2001 203 208 (Pubitemid 32611587)
134. T.B. Herbert, and S. Cohen Depression and immunity: a meta-analytic review Psychological Bulletin 113 1993 472 486
135. A. Seidel, V. Arolt, M. Hunstiger, L. Rink, A. Behnisch, and H. Kirchner Major depressive disorder is associated with elevated monocyte counts Acta Psychiatrica Scandinavica 94 1996 198 204 (Pubitemid 26313294)
136. M. Rothermundt, V. Arolt, J. Fenker, H. Gutbrodt, M. Peters, and H. Kirchner Different immune patterns in melancholic and non-melancholic major depression European Archives of Psychiatry and Clinical Neuroscience 251 2001 90 97 (Pubitemid 32488037)
137. D.S. Duch, J.H. Woolf, C.A. Nichol, J.R. Davidson, and J.C. Garbutt Urinary excretion of biopterin and neopterin in psychiatric disorders Psychiatry Research 11 1984 83 89 (Pubitemid 14155924)
138. P.R. Dunbar, J. Hill, T.J. Neale, and G.W. Mellsop Neopterin measurement provides evidence of altered cell-mediated immunity in patients with depression, but not with schizophrenia Psychological Medicine 22 1992 1051 1057 (Pubitemid 23007016)
139. M. Maes, S. Scharpe, H.Y. Meltzer, G. Okayli, E. Bosmans, and P. D'Hondt Increased neopterin and interferon-gamma secretion and lower availability of l-tryptophan in major depression: further evidence for an immune response Psychiatry Research 54 1994 143 160
140. S. Bonaccorso, A.H. Lin, R. Verkerk, F. Van Hunsel, I. Libbrecht, and S. Scharpe Immune markers in fibromyalgia: comparison with major depressed patients and normal volunteers Journal of Affective Disorders 48 1998 75 82 (Pubitemid 28078974)
141. N. Müller, A.M. Myint, and M.J. Schwarz Inflammatory biomarkers and depression Neurotoxicity Research 19 2011 308 318
142. M. Maes Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression Progress in Neuro- Psychopharmacology and Biological Psychiatry 35 2011 664 675
143. N. Matussek Neurobiologie und depression Medizinische Monatsschrift 3 1966 109 112
144. A. Coppen, and C. Swade 5-HT and depression: the present position M. Briley, G. Fillion, New concepts in depression 1988 MacMillan Press London 120 136
145. H. Anisman, and Z. Merali Anhedonic and anxiogenic effects of cytokine exposure Advances in Experimental Medicine and Biology 461 1999 199 233
146. H.E. Day, E.J. Curran, S.J. Watson Jr., and H. Akil Distinct neurochemical populations in the rat central nucleus of the amygdala and bed nucleus of the stria terminalis: evidence for their selective activation by interleukin-1beta Journal of Comparative Neurology 413 1999 113 128 (Pubitemid 29409755)
147. A.C. Linthorst, C. Flachskamm, P. Muller Preuss, F. Holsboer, and J.M. Reul Effect of bacterial endotoxin and interleukin-1 beta on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: an in vivo microdialysis study Journal of Neuroscience 15 1995 2920 2934
148. Z. Merali, S. Lacosta, and H. Anisman Effects of interleukin-1beta and mild stress on alterations of norepinephrine, dopamine and serotonin neurotransmission: a regional microdialysis study Brain Research 761 1997 225 235 (Pubitemid 27305981)
149. F. Shintani, T. Nakaki, S. Kanba, K. Sato, G. Yagi, and M. Shiozawa Involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocorticotropic hormone and in release of hypothalamic monoamines in the rat Journal of Neuroscience 15 1995 1961 1970
150. C. Song, Z. Merali, and H. Anisman Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2 or interleukin-6 treatment Neuroscience 88 1999 823 836 (Pubitemid 28518260)
151. S. Zalcman, J.M. Green-Johnson, L. Murray, D.M. Nance, D. Dyck, and H. Anisman Cytokine-specific central monoamine alterations induced by interleukin-1-2 and -6 Brain Research 643 1994 40 49 (Pubitemid 24115074)
152. G.M. Asnis, G.R. De La, S.R. Kohn, J.F. Reinus, M. Henderson, and J. Shah IFN-induced depression: a role for NSAIDs Psychopharmacology Bulletin 37 2003 29 50
153. C.L. Raison, L. Capuron, and A.H. Miller Cytokines sing the blues: inflammation and the pathogenesis of depression Trends in Immunology 27 2006 24 31 (Pubitemid 43083561)
154. M. Schäfer, M. Horn, F. Schmidt, M.H. Schmid-Wendtner, M. Volkenandt, and M. Ackenheil Correlation between sICAM-1 and depressive symptoms during adjuvant treatment of melanoma with interferon-alpha Brain, Behavior, and Immunity 18 2004 555 562 (Pubitemid 39149775)
155. N. Müller, M.J. Schwarz, and M. Riedel COX-2 inhibition in schizophrenia: focus on clinical effects of celecoxib therapy and the role of TNF-alpha W.W. Eaton, Medical and psychiatric comorbidity over the course of life 2005 American Psychiatric Publishing Washington, DC 265 276
156. N. Müller, and M.J. Schwarz The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression Molecular Psychiatry 11 2007 998 1000
157. D. Braun, R.S. Longman, and M.L. Albert A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation Blood 106 2005 2375 2381 (Pubitemid 41510810)
158. E. Kwidzinski, J. Bunse, O. Aktas, D. Richter, L. Mutlu, and F. Zipp Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation FASEB Journal 19 2005 1347 1349 (Pubitemid 41113745)
159. C.M. Robinson, P.T. Hale, and J.M. Carlin The role of IFN-gamma and TNF-alpha-responsive regulatory elements in the synergistic induction of indoleamine dioxygenase Journal of Interferon and Cytokine Research 25 2005 20 30 (Pubitemid 40105588)
160. J.S. Kim, W. Schmid-Burgk, D. Claus, and H.H. Kornhuber Increased serum glutamate in depressed patients Archiv fur Psychiatrie und Nervenkrankheiten 232 1982 299 304 (Pubitemid 13124834)
161. C.A. Altamura, M.C. Mauri, A. Ferrara, A.R. Moro, G. D'Andrea, and F. Zamberlan Plasma and platelet excitatory amino acids in psychiatric disorders American Journal of Psychiatry 150 1993 1731 1733 (Pubitemid 23325960)
162. M.C. Mauri, A. Ferrara, L. Boscati, S. Bravin, F. Zamberlan, and M. Alecci Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment Neuropsychobiology 37 1998 124 129 (Pubitemid 28171767)
163. M. Maes, R. Verkerk, E. Vandoolaeghe, A. Lin, and S. Scharpe Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity Acta Psychiatrica Scandinavica 97 1998 302 308 (Pubitemid 28179268)
164. A. Kugaya, and G. Sanacora Beyond monoamines: glutamatergic function in mood disorders CNS Spectrums 10 2005 808 819 (Pubitemid 41531934)
165. G. Sanacora, R. Gueorguieva, C.N. Epperson, Y.T. Wu, M. Appel, and D.L. Rothman Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression Archives of General Psychiatry 61 2004 705 713 (Pubitemid 38890805)
166. J. Maj, Z. Rogoz, G. Skuza, and H. Sowinska Effects of MK-801 and antidepressant drugs in the forced swimming test in rats European Neuropsychopharmacology 2 1992 37 41
167. R. Trullas, and P. Skolnick Functional antagonists at the NMDA receptor complex exhibit antidepressant actions European Journal of Pharmacology 185 1990 1 10 (Pubitemid 20254891)
168. A. Yilmaz, D. Schulz, A. Aksoy, and R. Canbeyli Prolonged effect of an anesthetic dose of ketamine on behavioral despair Pharmacology Biochemistry and Behavior 71 2002 341 344
169. G. Ossowska, B. Klenk-Majewska, and G. Szymczyk The effect of NMDA antagonists on footshock-induced fighting behavior in chronically stressed rats Journal of Physiology and Pharmacology 48 1997 127 135 (Pubitemid 27173353)
170. T.J. Huber, D.E. Dietrich, and H.M. Emrich Possible use of amantadine in depression Pharmacopsychiatry 32 1999 47 55 (Pubitemid 29197549)
171. R. Stryjer, R.D. Strous, G. Shaked, F. Bar, B. Feldman, and M. Kotler Amantadine as augmentation therapy in the management of treatment-resistant depression International Clinical Psychopharmacology 18 2003 93 96 (Pubitemid 36343978)
172. G. Crane Cyloserine as an antidepressant agent American Journal of Psychiatry 115 1959 1025 1026
173. C. Song, and B.E. Leonard Fundamentals of psychoneuroimmunology 2000 J Wiley and Sons Chichester, New York
174. H. Besedovsky, R.A. del, E. Sorkin, P.M. Da, R. Burri, and C. Honegger The immune response evokes changes in brain noradrenergic neurons Science 221 1983 564 566 (Pubitemid 13074686)
175. M.J. Schwarz, S. Chiang, N. Müller, and M. Ackenheil T-helper-1 and T-helper-2 responses in psychiatric disorders Brain, Behavior, and Immunity 15 2001 340 370 (Pubitemid 34044520)
176. A.M. Myint, and Y.K. Kim Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression Medical Hypotheses 61 2003 519 525 (Pubitemid 37411894)
177. A.M. Myint, Y.K. Kim, R. Verkerk, S. Scharpe, H. Steinbusch, and B. Leonard Kynurenine pathway in major depression: evidence of impaired neuroprotection Journal of Affective Disorders 98 2007 143 151 (Pubitemid 46048912)
178. N. Gogtay, A. Lu, A.D. Leow, A.D. Klunder, A.D. Lee, and A. Chavez Three-dimensional brain growth abnormalities in childhood-onset schizophrenia visualized by using tensor-based morphometry Proceedings of the National Academy of Sciences of the United States of America 105 2008 15979 15984
179. R.G. Steen, C. Mull, R. McClure, R.M. Hamer, and J.A. Lieberman Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies British Journal of Psychiatry 188 510-518 2006 510 518 (Pubitemid 43844097)
180. D.E. Job, H.C. Whalley, A.M. McIntosh, D.G. Owens, E.C. Johnstone, and S.M. Lawrie Grey matter changes can improve the prediction of schizophrenia in subjects at high risk BMC Medicine 4 2006 29
181. M.H. Chakos, S.A. Schobel, H. Gu, G. Gerig, D. Bradford, and C. Charles Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia British Journal of Psychiatry 186 2005 26 31 (Pubitemid 40070540)
182. E.M. Meisenzahl, D. Rujescu, A. Kirner, I. Giegling, N. Kathmann, and G. Leinsinger Association of an interleukin-1beta genetic polymorphism with altered brain structure in patients with schizophrenia American Journal of Psychiatry 158 2001 1316 1319 (Pubitemid 32717709)
183. J.J. Versijpt, F. Dumont, K.J. Van Laere, D. Decoo, P. Santens, and K. Audenaert Assessment of neuroinflammation and microglial activation in Alzheimer's disease with radiolabelled PK11195 and single photon emission computed tomography. A pilot study European Neurology 50 2003 39 47 (Pubitemid 36736968)
184. B.N. van Berckel, M.G. Bossong, R. Boellaard, R. Kloet, A. Schuitemaker, and E. Caspers Microglia activation in recent-onset schizophrenia: a quantitative (R)-11CPK11195 positron emission tomography study Biological Psychiatry 64 2008 820 822
185. J. Doorduin, E.F. de Vries, A.T. Willemsen, J.C. de Groot, R.A. Dierckx, and H.C. Klein Neuroinflammation in schizophrenia-related psychosis: a PET study Journal of Nuclear Medicine 50 2009 1801 1807
186. A. Takano, R. Arakawa, H. Ito, A. Tateno, H. Takahashi, and R. Matsumoto Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with 11CDAA1106 International Journal of Neuropsychopharmacology 13 2010 943 950
187. T. Frodl, E.M. Meisenzahl, T. Zetzsche, C. Born, C. Groll, and M. Jager Hippocampal changes in patients with a first episode of major depression American Journal of Psychiatry 159 2002 1112 1118 (Pubitemid 34743250)
188. T.S. Frodl, N. Koutsouleris, R. Bottlender, C. Born, M. Jager, and I. Scupin Depression-related variation in brain morphology over 3 years: effects of stress? Archives of General Psychiatry 65 2008 1156 1165
189. D. Cotter, C. Pariante, and G. Rajkowska Glial pathology in major psychiatric disorders G. Agam, R.H. Belmaker, I. Everall, The post-mortem brain in psychiatric research 2002 Kluwer Academic Publishers Boston 291 324
190. D. Ongur, W.C. Drevets, and J.L. Price Glial reduction in the subgenual prefrontal cortex in mood disorders Proceedings of the National Academy of Sciences of the United States of America 95 1998 13290 13295 (Pubitemid 28509564)
191. G. Rajkowska, J.J. Miguel-Hidalgo, J. Wei, G. Dilley, S.D. Pittman, and H.Y. Meltzer Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression Biological Psychiatry 45 1999 1085 1098 (Pubitemid 29236550)
192. G. Rajkowska, A. Halaris, and L.D. Selemon Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder Biological Psychiatry 49 2001 741 752 (Pubitemid 32452295)
193. G. Rajkowska Depression: what we can learn from postmortem studies Neuroscientist 9 2003 273 284 (Pubitemid 36899115)
194. N.L. Johnston-Wilson, C.D. Sims, J.-P. Hofmann, L. Anderson, A.D. Shore, and E.F. Torrey Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder Molecular Psychiatry 5 2000 142 149 (Pubitemid 30229428)
195. J.J. Miguel-Hidalgo, C. Baucom, G. Dilley, J.C. Overholser, H.Y. Meltzer, and C.A. Stockmeier Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder Biological Psychiatry 48 2000 861 873
196. X. Si, J.J. Miguel-Hidalgo, G. O'Dwyer, C.A. Stockmeier, and G. Rajkowska Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression Neuropsychopharmacology 29 2004 2088 2096 (Pubitemid 39486561)
197. S. Davis, A. Thomas, R. Perry, A. Oakley, R.N. Kalaria, and J.T. O'Brien Glial fibrillary acidic protein in late life major depressive disorder: an immunocytochemical study Journal of Neurology, Neurosurgery and Psychiatry 73 2002 556 560 (Pubitemid 35246811)
198. J. Wagner von Jauregg Fieberbehandlung bei Psychosen Wiener Medizinische Wochenschrift 76 1926 79 82
199. N. Müller, M. Riedel, M.J. Schwarz, and R.R. Engel Clinical effects of COX-2 inhibitors on cognition in schizophrenia European Archives of Psychiatry and Clinical Neuroscience 255 2005 149 151 (Pubitemid 40558607)
200. N. Müller COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence Current Opinion in Investigational Drugs 11 2010 31 42
201. N. Müller, D. Krause, S. Dehning, R. Musil, R. Schennach-Wolff, and M. Obermeier Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment Schizophrenia Research 121 2010 119 124
202. W. Laan, D.E. Grobbee, J.P. Selten, C.J. Heijnen, R.S. Kahn, and H. Burger Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial Journal of Clinical Psychiatry 71 2010 520 527
203. I.E. Sommer, W.L. de, M. Begemann, and R.S. Kahn Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis Journal of Clinical Psychiatry 73 2012 414 419
204. H. Mizoguchi, K. Takuma, A. Fukakusa, Y. Ito, A. Nakatani, and D. Ibi Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice Psychopharmacology (Berl) 196 2008 233 241
205. Y. Levkovitz, S. Mendlovich, S. Riwkes, Y. Braw, H. Levkovitch-Verbin, and G. Gal A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia Journal of Clinical Psychiatry 71 2010 138 149
206. I.B. Chaudhry, J. Hallak, N. Husain, F. Minhas, J. Stirling, and P. Richardson Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment Journal of Psychopharmacology 26 2012 1185 1193
207. N. Ahuja, and B.T. Carroll Possible anti-catatonic effects of minocycline in patients with schizophrenia Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 2007 968 969 (Pubitemid 46671479)
208. M. Sandrini, G. Vitale, and L.A. Pini Effect of rofecoxib on nociception and the serotonin system in the rat brain Inflammation Research 51 2002 154 159 (Pubitemid 34297854)
209. A.M. Myint, H.W. Steinbusch, L. Goeghegan, D. Luchtman, Y.K. Kim, and B.E. Leonard Effect of the COX-2 inhibitor celecoxib on behavioural and immune changes in an olfactory bulbectomised rat model of depression Neuroimmunomodulation 14 2007 65 71 (Pubitemid 47442983)
210. N. Brunello, S. Alboni, G. Capone, C. Benatti, J.M. Blom, and F. Tascedda Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in the chronic escape deficit model of depression International Clinical Psychopharmacology 21 2006 219 225 (Pubitemid 43740299)
211. N. Müller, M.J. Schwarz, S. Dehning, A. Douhet, A. Cerovecki, and B. Goldstein-Müller The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine Molecular Psychiatry 11 2006 680 684 (Pubitemid 43989814)
212. S. Akhondzadeh, S. Jafari, F. Raisi, and A. Ghoreishi A clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial Booklet - WPA Section on Immunology and Psychiatry - Workshop PsychoNeuroImmunology 2008 [Ref type: Abstract]
213. S. Akhondzadeh, S. Jafari, F. Raisi, A.A. Nasehi, A. Ghoreishi, and B. Salehi Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial Depression and Anxiety 26 2009 607 611
214. S.H. Abbasi, F. Hosseini, A. Modabbernia, M. Ashrafi, and S. Akhondzadeh Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study Journal of Affective Disorders 141 2012 308 314
215. S. Tyring, A. Gottlieb, K. Papp, K. Gordon, C. Leonardi, and A. Wang Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial Lancet 367 2006 29 35 (Pubitemid 43038667)
216. C.L. Raison, R.E. Rutherford, B.J. Woolwine, C. Shuo, P. Schettler, and D.F. Drake A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers JAMA Psychiatry 70 2013 31 41
217. J. Benicky, E. Sanchez-Lemus, M. Honda, T. Pang, M. Orecna, and J. Wang Angiotensin II AT(1) receptor blockade ameliorates brain inflammation Neuropsychopharmacology 36 2011 857 870
218. J.M. Saavedra, E. Sanchez-Lemus, and J. Benicky Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: therapeutic implications Psychoneuroendocrinology 36 2011 1 18
219. N. Craddock, and M.J. Owen The Kraepelinian dichotomy - going, going, but still not gone British Journal of Psychiatry 196 2010 92 95
220. A. Dutt, T. Ganguly, M. Shaikh, M. Walshe, K. Schulze, and N. Marshall Association between hippocampal volume and P300 event related potential in psychosis: support for the Kraepelinian divide Neuroimage 59 2012 997 1003
221. E. Radonic, M. Rados, P. Kalember, M. Bajs-Janovic, V. Folnegovic-Smalc, and N. Henigsberg Comparison of hippocampal volumes in schizophrenia, schizoaffective and bipolar disorder Collegium Antropologicum 35 Suppl. 1 2011 249 252
222. J.B. Savitz, A.C. Nugent, W. Bogers, J.P. Roiser, E.E. Bain, and A. Neumeister Habenula volume in bipolar disorder and major depressive disorder: a high-resolution magnetic resonance imaging study Biological Psychiatry 69 2011 336 343
223. C. Winter, B. Vollmayr, A. Djodari-Irani, J. Klein, and A. Sartorius Pharmacological inhibition of the lateral habenula improves depressive-like behavior in an animal model of treatment resistant depression Behavioural Brain Research 216 2011 463 465
224. N. Müller, and M.J. Schwarz A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disorders European Archives of Psychiatry and Clinical Neuroscience 258 Suppl. 2 2008 97 106 (Pubitemid 351758763)
225. K. Bechter Updating the mild encephalitis hypothesis of schizophrenia Progress in Neuro-Psychopharmacology & Biological Psychiatry 42 2013 71 91
226. F. Lederbogen, P. Kirsch, L. Haddad, F. Streit, H. Tost, and P. Schuch City living and urban upbringing affect neural social stress processing in humans Nature 474 7352 2011 498 501
227. C.J. Morgan, S. Duffin, S. Hunt, L. Monaghan, O. Mason, and H.V. Curran Neurocognitive function and schizophrenia-proneness in individuals dependent on ketamine, on high potency cannabis ('skunk') or on cocaine Pharmacopsychiatry 45 7 2012 269 274
228. C. Nathan Points of control in inflammation Nature 19-26 420 2002 846 852 (Pubitemid 36019637)
229. M. Cherner, L. Cysique, R.K. Heaton, T.D. Marcotte, R.J. Ellis, and E. Masliah Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders Journal of Neurovirology 13 2007 23 28 (Pubitemid 46510141)
230. A.S. Brown Prenatal infection as a risk factor for schizophrenia Schizophr Bulletin 32 2006 200 202